TJHA
NVO

Thomas J. Herzfeld Advisors’s Novo Nordisk NVO Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-944
Closed -$85.8K – 277
2023
Q3 		$85.8K Buy
944
+126
+15% +$11.1K 0.03% 110
2023
Q2 		$66.2K Buy
818
+40
+5% +$3.27K 0.03% 109
2023
Q1 		$61.9K Sell
778
-328
-30% -$23.3K 0.03% 99
2022
Q4 		$74.8K Sell
1,106
-376
-25% -$22K 0.03% 98
2022
Q3 		$74K Buy
1,482
+60
+4% +$3.21K 0.03% 94
2022
Q2 		$79K Sell
1,422
-432
-23% -$24K 0.03% 101
2022
Q1 		$103K Buy
1,854
+356
+24% +$18.3K 0.04% 106
2021
Q4 		$84K Buy
1,498
+608
+68% +$32.9K 0.03% 125
2021
Q3 		$43K Buy
890
+770
+642% +$37.2K 0.02% 143
2021
Q2 		$5K Buy
120
+32
+36% +$1.24K ﹤0.01% 271
2021
Q1 		$3K Hold
88
– – ﹤0.01% 308
2020
Q4 		$3K Hold
88
– – ﹤0.01% 268
2020
Q3 		$3K Buy
88
+26
+42% +$867 ﹤0.01% 222
2020
Q2 		$2K Buy
+62
New +$1.98K ﹤0.01% 276
2015
Q3 		– Sell
-812
Closed -$22K – 333
2015
Q2 		$22K Buy
+812
New +$22.8K 0.01% 243

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Thomas J. Herzfeld Advisors's NVO Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Novo Nordisk (NVO) in Q4 2023, closing a stake of 944 shares — an estimated $85.8K sold.

Thomas J. Herzfeld Advisors first reported a position in NVO in Q2 2015 and held it in 15 quarters. The position peaked at $103K in Q1 2022. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Thomas J. Herzfeld Advisors reported no remaining Novo Nordisk position as of Q4 2023 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 944 Novo Nordisk shares in Q4 2023, an estimated $85.8K.
  • Thomas J. Herzfeld Advisors first reported a position in Novo Nordisk in Q2 2015 and held it in 15 quarters.
  • Thomas J. Herzfeld Advisors's Novo Nordisk position peaked at $103K in Q1 2022.
  • 1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.